Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

From 40 to 74, the US Preventive Services Task Force advises every two years for screening mammography.

2.

FDA Approves Next-Gen Agent for Mantle Cell Lymphoma

3.

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

4.

Could the Prostate Cancer Story of Francis Collins Dissuade Men from Active Surveillance?

5.

High Success Rate With Conversion Therapy for Unresectable Gastroesophageal Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot